0001666071-20-000259.txt : 20200828
0001666071-20-000259.hdr.sgml : 20200828
20200828160903
ACCESSION NUMBER: 0001666071-20-000259
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200826
FILED AS OF DATE: 20200828
DATE AS OF CHANGE: 20200828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laube Lynne Marie
CENTRAL INDEX KEY: 0001730687
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 201147951
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_159864532852688.xml
FORM 4
X0306
4
2020-08-26
0
0001666071
Cardlytics, Inc.
CDLX
0001730687
Laube Lynne Marie
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
1
1
0
0
Chief Executive Officer
Common Stock
2020-08-26
4
M
0
14062
A
305385
D
Common Stock
2020-08-27
4
S
0
2241
80.18
D
303144
D
Common Stock
2020-08-27
4
S
0
2896
80.90
D
300248
D
Common Stock
2020-08-27
4
S
0
1260
81.76
D
298988
D
Common Stock
14565
I
See Footnote
Common Stock
14565
I
See Footnote
Performance Stock Unit
2020-08-26
4
M
0
14062
0
D
Common Stock
14062.0
14062
D
Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $79.58 to $80.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $80.58 to $81.57, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $81.61 to $81.90, inclusive.
The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.
On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on August 26, 2020, 12 months after the Certification.
/s/ Kirk Somers, Attorney-in-Fact
2020-08-28